The Utah Medical Licensing Board objects to artificial intelligence that bypasses physician approval for drug refills.
As a medical student and researcher, I was shocked by the brazen inequity of the trial. Randomized controlled trials have ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that its third batch of pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results